Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Merck reaches an antibody drug acquisition agreement worth over 800 million dollars

Merck reaches an antibody drug acquisition agreement worth over 800 million dollars

格隆汇格隆汇2026/03/31 13:56
Show original
Glonghui, March 31st | According to Yicai, biopharmaceutical company Infinimmune has announced an agreement with Merck & Co. to develop multiple antibodies targeting various disease targets. The total value of this deal is expected to reach approximately $838 million. Infinimmune stated that it will use its proprietary platform to screen human immune cells and identify naturally occurring antibodies, then further develop these antibodies using AI tools. Merck & Co. will have exclusive rights to develop and commercialize the antibody drug candidates resulting from the collaboration.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Smart ring manufacturer Oura (OURA.US) IPO reportedly oversubscribed by about 4 times

According to market sources, the initial public offering (IPO) of smart ring manufacturer Oura in the US stock market has reportedly been oversubscribed by approximately four times.

智通财经•2026/09/26 03:46